Clinical Trial Material
During the clinical stage of development, API requirements for quality and scale are rapidly evolving. All the while, new risks are introduced as processes are scaled up to meet supply demands for clinical trials. As process knowledge rapidly evolves and first-hand manufacturing experience is achieved, sponsor and CDMO better understand risk as practical or theoretical. Managing risk while maintaining timelines requires careful planning, execution, monitoring and excellent communication. Project management needs to be highly experienced to lead interdisciplinary teams and ensure all aspects of synthesis, engineering and analytical are considered and controlled using phase-appropriate approaches.